Skip to content
Two Biotechnology Innovation Organization (BIO) members – BioMarin and Twist Bioscience – were recognized at the 2023 Pantheon Awards on Wednesday for innovative achievements […]
BioMarin, Twist Bioscience win CLS Pantheon Awards Read More »
The 2023 Biotechnology Innovation Organization (BIO) Investor Forum ended the way it began: with caution about the months ahead and hope companies will continue
The market outlook for life science – and how biotechs can weather the storm Read More »
A lot of great science—and future cures—originates in a university. But while the majority of basic biological research is conducted in an academic setting,
How to succeed at tech transfer – and get great science to patients Read More »
The only constant is change. The trick for entrepreneurs and investors, it would seem, is to map and anticipate that change and operate with
What investors look for in early-stage companies Read More »
The Biotechnology Innovation Organization (BIO) Investor Forum 2023 is taking place October 17-18, 2023, in San Francisco, California, bringing together biotech startups and drug
BIO Investor Forum 2023 kicks off – here’s why biotech investment matters Read More »
The Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs are a great way for companies to kick-start their business. However, navigating the
What you need to know about applying for SBIR/STTR grants Read More »
Since 1999, Joe Panetta has been President & CEO and a board member of Biocom California, the state’s advocate for the life sciences industry.
How a 2017 IRS tax law could bankrupt small American biotech companies in 2023 Read More »
Biotech was front and center as Biotechnology Innovation Organization (BIO) CEO Rachel King met with Maryland Governor Wes Moore at the University of Maryland
BIO CEO meets Maryland Governor to highlight state’s vital relationship with biotech Read More »
It’s pretty common to hear life sciences organizations talk about talent as the linchpin of their success. But what does it really mean when
Vision, collaboration, and patience create a strong biopharma talent pipeline Read More »
At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back innovation and research, but are concerned that it may be “misused
Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers Read More »
